Pyxis Oncology, Inc. - PYXS
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 08, 2026 | CEO & Chairman of the Board | A | A | 2,503,050.0 | 0.0 | 0.0 | 2,503,050.0 | View | |
| Aug 20, 2026 | — | A | A | 46,000.0 | 0.0 | 0.0 | 46,000.0 | View | |
| Aug 14, 2026 | Interim CEO | A | A | 250,956.0 | 0.0 | 0.0 | 941,087.0 | View | |
| Jul 02, 2026 | — | M | D | 35,000.0 | 0.0 | 0.0 | 357,461.0 | View | |
| Jul 02, 2026 | — | S | D | 35,000.0 | 3.06 | 107,100.0 | 38,741.0 | View | |
| Jul 02, 2026 | — | M | A | 35,000.0 | 1.6 | 56,000.0 | 73,741.0 | View |